Tactile Systems Technology (TCMD) Expected to Announce Quarterly Earnings on Monday

Key Points

• Q1 2026 earnings are scheduled after the market close on May 4, 2026, with analysts projecting EPS of ($0.07) and revenue of about $70.57 million.
• Tactile Systems recently beat expectations in its prior quarter (EPS $0.46, revenue $103.59M) and analysts forecast roughly $1.00 EPS for the current and next fiscal years; the stock trades near $25 with a market cap of about $570M and a P/E around 30.
• Insider selling has been notable—CEO and CFO sold shares and insiders sold 50,137 shares (~$1.43M) in the last 90 days—while institutional investors own ~83.4% of the stock and the analyst consensus is a "Moderate Buy" with a $37.40 target.

Tactile Systems Technology (NASDAQ:TCMD - Get Free Report) will likely be announcing its Q1 2026 results after the market closes on Monday, May 4th. Analysts expect the company to announce earnings of ($0.07) per share and revenue of $70.5710 million for the quarter. Investors may visit the the company's upcoming Q1 2026 earning results page for the latest details on the call scheduled for Monday, May 4, 2026 at 5:00 PM ET.

Tactile Systems Technology (NASDAQ:TCMD - Get Free Report) last released its earnings results on Tuesday, February 17th. The company reported $0.46 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.44 by $0.02. Tactile Systems Technology had a return on equity of 9.26% and a net margin of 5.79%.The firm had revenue of $103.59 million for the quarter, compared to analyst estimates of $93.80 million. On average, analysts expect Tactile Systems Technology to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Tactile Systems Technology Stock Performance

Shares of NASDAQ:TCMD opened at $25.07 on Monday. The firm has a market capitalization of $570.34 million, a PE ratio of 30.20 and a beta of 0.99. Tactile Systems Technology has a 1-year low of $8.61 and a 1-year high of $37.77. The business's 50 day moving average is $26.87 and its 200-day moving average is $25.79.

Insider Activity at Tactile Systems Technology

In related news, CEO Sheri Louise Dodd sold 10,993 shares of the business's stock in a transaction on Tuesday, February 24th. The stock was sold at an average price of $28.94, for a total value of $318,137.42. Following the sale, the chief executive officer owned 243,885 shares of the company's stock, valued at $7,058,031.90. The trade was a 4.31% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Elaine M. Birkemeyer sold 7,701 shares of the business's stock in a transaction on Tuesday, February 24th. The shares were sold at an average price of $28.94, for a total value of $222,866.94. Following the completion of the sale, the chief financial officer directly owned 134,819 shares in the company, valued at approximately $3,901,661.86. This represents a 5.40% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 50,137 shares of company stock valued at $1,434,839 in the last 90 days. 2.10% of the stock is owned by corporate insiders.

Institutional Trading of Tactile Systems Technology

Several institutional investors have recently bought and sold shares of TCMD. Goldman Sachs Group Inc. boosted its stake in Tactile Systems Technology by 2.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 186,936 shares of the company's stock valued at $2,471,000 after buying an additional 3,898 shares in the last quarter. Rhumbline Advisers raised its position in Tactile Systems Technology by 4.0% in the 2nd quarter. Rhumbline Advisers now owns 37,780 shares of the company's stock valued at $383,000 after purchasing an additional 1,441 shares during the last quarter. American Century Companies Inc. raised its position in Tactile Systems Technology by 11.2% in the 2nd quarter. American Century Companies Inc. now owns 53,264 shares of the company's stock valued at $540,000 after purchasing an additional 5,364 shares during the last quarter. Prudential Financial Inc. raised its position in Tactile Systems Technology by 3.5% in the 2nd quarter. Prudential Financial Inc. now owns 24,360 shares of the company's stock valued at $247,000 after purchasing an additional 835 shares during the last quarter. Finally, Norges Bank bought a new position in Tactile Systems Technology in the 2nd quarter valued at $1,464,000. Institutional investors and hedge funds own 83.43% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the company. Piper Sandler boosted their price objective on Tactile Systems Technology from $35.00 to $42.00 and gave the company an "overweight" rating in a research report on Wednesday, February 18th. Weiss Ratings restated a "hold (c+)" rating on shares of Tactile Systems Technology in a research report on Friday, March 27th. Zacks Research cut Tactile Systems Technology from a "strong-buy" rating to a "hold" rating in a research report on Monday, January 5th. B. Riley Financial boosted their price objective on Tactile Systems Technology from $16.00 to $32.00 and gave the company a "neutral" rating in a research report on Wednesday, February 18th. Finally, Lake Street Capital set a $40.00 price objective on Tactile Systems Technology and gave the company a "buy" rating in a research report on Wednesday, February 18th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $37.40.

About Tactile Systems Technology

Tactile Systems Technology, Inc, headquartered in Plymouth, Minnesota, is a medical device company specializing in the design, manufacture and marketing of home-use pneumatic compression therapy systems for the treatment of lymphedema and other chronic edema-related conditions. Using proprietary software and patented pump technologies, the company's platforms are designed to improve patient outcomes through sequential pressure treatment that promotes fluid mobilization and enhanced lymphatic function.

At the core of Tactile Systems' product portfolio is the Flexitouch® system, a programmable pneumatic pump and garment system approved for home use, and the Aria® device, which features an intuitive touchscreen interface and advanced garment design.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.